Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis. [electronic resource]
Producer: 20200423ISSN:- 1469-493X
- Antibodies, Monoclonal -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bortezomib -- therapeutic use
- Humans
- Lenalidomide -- therapeutic use
- Multiple Myeloma -- drug therapy
- Network Meta-Analysis
- Randomized Controlled Trials as Topic
- Thalidomide -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.